Rentokil Initial (LON:RTO – Free Report) had its price target decreased by JPMorgan Chase & Co. from GBX 477 to GBX 431 in a research report report published on Friday,Digital Look reports. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Other analysts also recently issued reports about the stock. Citigroup decreased their price objective on shares of Rentokil Initial from GBX 575 to GBX 550 and set a “buy” rating on the stock in a research report on Friday. Royal Bank Of Canada dropped their target price on shares of Rentokil Initial from GBX 540 to GBX 480 and set an “outperform” rating for the company in a report on Thursday. Finally, Jefferies Financial Group reiterated a “buy” rating and issued a GBX 550 price target on shares of Rentokil Initial in a research note on Thursday, July 9th. Five investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of GBX 463.
Get Our Latest Analysis on Rentokil Initial
Rentokil Initial Stock Performance
Rentokil Initial Company Profile
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers. The company provides hygiene services, including the provision and maintenance of products, such as soap and hand sanitizer dispensers, hand dryers, air care and purification, cubicle and surface sanitizers, feminine hygiene units, toilet paper dispensers, and floor protection mats.
Further Reading
- Five stocks we like better than Rentokil Initial
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.
